Patents-Review.com
ClassID:

110532 ⎘

C12N2750/14071 - CPC Classification

Classification description:

ssDNA viruses; Details; Parvoviridae Demonstrated effect

Recent Application in this class:
#1
20260131032
2026-05-14

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHY

 #2
20250179441
2025-06-05

ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY

 #3
20250109408
2025-04-03

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #4
20250109407
2025-04-03

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #5
20240101969
2024-03-28

Adeno-associated virus compositions for targeted gene therapy

 #6
20240067974
2024-02-29

METHOD OF ALLELE SPECIFIC SILENCING FOR THE TREATMENT OF AUTOSOMAL DOMINANT CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)

 #7
20230416700
2023-12-28

COMPOSITIONS USEFUL IN TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

 #8
20230374546
2023-11-23

BIDIRECTIONAL DUAL PROMOTER EXPRESSION VECTORS AND USES THEREOF

 #9
20230241252
2023-08-03

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHY

 #10
20230078668
2023-03-16

Methods of vaccine administration

 #11
20230033866
2023-02-02

COMPOSITIONS AND METHODS FOR THE TARGETING OF RHODOPSIN

 #12
20220332792
2022-10-20

ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF

 #13
20220324928
2022-10-13

Zinc Finger Protein Transcription Factors for Repressing Alpha-Synuclein Expression

 #14
20220249702
2022-08-11

GENE THERAPY FOR RETINAL DISEASE

 #15
20220119775
2022-04-21

ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY

 #16
20220090128
2022-03-24

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #17
20210388332
2021-12-16

GENE EDITING SYSTEM FOR CORRECTING SPLICING DEFECTS

 #18
20210340565
2021-11-04

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #19
20210189401
2021-06-24

Method of allele specific silencing for the treatment of autosomal dominant Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

 #20
20210171982
2021-06-10

IMPROVED CLINICAL PARAMETERS BY EXPRESSION OF FACTOR VIII

 #21
20200377866
2020-12-03

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #22
20200316192
2020-10-08

Methods of vaccine administration

 #23
20200165576
2020-05-28

Adeno-associated virus compositions for targeted gene therapy

 #24
20200157564
2020-05-21

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #25
20190071651
2019-03-07

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #26
20180334687
2018-11-22

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #27
20180135030
2018-05-17

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #28
20170051259
2017-02-23

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #29
20170021037
2017-01-26

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #30
20160228369
2016-08-11

Dry formulations of vaccines that are room temperature stable

 #31
20150313969
2015-11-05

Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia

 #32
20150182619
2015-07-02

Methods of vaccine administration

 #33
20140221462
2014-08-07

Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia

 #34
20120263756
2012-10-18

Vaccines containing canine parvovirus genetic variants

 #35
20100028379
2010-02-04

METHODS OF VACCINE ADMINISTRATION

 #36
20090098152
2009-04-16

Vaccines containing canine parvovirus genetic variants

 #37
20090010955
2009-01-08

Vaccines containing canine parvovirus genetic variants